OTHER
Therapeutics
Review: continuous positive airway pressure devices are effective and cost-effective for obstructive sleep apnoea
| The first 150 words of the full text of this article appear below. |
Are continuous positive airway pressure (CPAP) devices effective and cost-effective for treatment of obstructive sleep apnoea-hypopnoea syndrome (OSAHS)?
Included studies compared CPAP devices (used for
1 wk) with placebo, supportive or usual care, or dental devices in adults (
16 y of age) with OSAHS. Studies in patients with central nervous system dysfunction or heart failure were excluded. Outcomes included subjective daytime sleepiness (Epworth Sleepiness Scale, ESS), ability to stay awake (Maintenance of Wakefulness Test, MWT), blood pressure (BP), and cost-effectiveness.
15 electronic databases including Medline, CINAHL, EMBASE/Excerpta Medica, and Cochrane Central Register of Controlled Trials (to Nov 2006); journals (2005 to May 2007); conference proceedings (2005–6); industry submissions; and the reference list of a previous Cochrane review on the topic were searched for randomised controlled trials (RCTs). 48 RCTs (n = 2521, mean age 44–58 y, 52–100% men) met the selection criteria. Duration of most trials was 4–12
Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
